Budesonide is a corticosteroid used to treat a wide range of inflammatory conditions, from asthma and allergies to Crohn’s disease, ulcerative colitis, and certain kidney and esophageal disorders. What makes it unusual among steroids is its versatility: it comes in inhalers, nasal sprays, oral capsules, tablets, and liquid suspensions, each designed to deliver the drug directly where inflammation is happening while minimizing the body’s overall exposure to it.
How Budesonide Works
Budesonide reduces inflammation by dialing down the immune system’s overreaction in targeted tissues. In the airways, it decreases the number of inflammatory cells and chemical signals that cause swelling, mucus production, and hypersensitivity. In the gut, it calms the immune attack on the intestinal lining that drives conditions like Crohn’s disease and ulcerative colitis.
One of budesonide’s key properties is that it stays active locally rather than flooding the entire body. When applied to airway tissue, for example, it forms fatty acid compounds inside cells that essentially anchor it in place, extending its anti-inflammatory effect. Once it does enter the bloodstream, the liver breaks it down rapidly into byproducts that have less than 1% of the original drug’s potency. This “high local activity, low systemic activity” profile is why budesonide tends to cause fewer whole-body steroid side effects than older corticosteroids like prednisone.
Asthma and Airway Conditions
Budesonide is one of the most widely prescribed inhaled corticosteroids for asthma. Sold under the brand name Pulmicort (as both a dry powder inhaler and a nebulizer suspension), it serves as a daily controller medication that prevents asthma symptoms rather than treating attacks after they start. For some patient groups, the drug’s ability to remain active inside airway cells allows for once-daily dosing.
In recent years, international asthma guidelines have shifted toward pairing budesonide with a fast-acting bronchodilator called formoterol in a single inhaler. The Global Initiative for Asthma now recommends this combination as the preferred approach for adolescents and adults across all severity levels. In a strategy called SMART (single maintenance and reliever therapy), patients use the same budesonide-formoterol inhaler for both daily prevention and symptom relief, replacing the traditional separate rescue inhaler. This approach is associated with a 30% lower risk of severe asthma flare-ups compared to using a standard rescue inhaler alongside a separate controller.
Nasal Allergies
Budesonide nasal spray (sold over the counter as Rhinocort) is a first-line treatment for seasonal and year-round allergic rhinitis. Sprayed directly into the nasal passages, it reduces the swelling, congestion, sneezing, and runny nose that come with hay fever and other nasal allergies. Because it acts locally in the nose, very little reaches the rest of the body. Most people notice improvement within a day or two, though it can take up to two weeks of consistent daily use for the full effect.
Crohn’s Disease
Oral budesonide capsules (Entocort EC) are approved for treating active Crohn’s disease in adults and children aged 8 and older. The capsules use a delayed-release coating designed to dissolve in the ileum and ascending colon, the areas of the gut most commonly affected by Crohn’s. This targeted delivery means budesonide can calm intestinal inflammation without the same degree of side effects seen with systemic steroids. It is used both to bring active flares under control and to help maintain remission once symptoms have settled.
Ulcerative Colitis
A different oral formulation, budesonide extended-release tablets (Uceris), is designed specifically for mild to moderate ulcerative colitis. These tablets use a technology that distributes the drug throughout the colon, matching the pattern of inflammation in UC. The standard approach is 9 mg taken once each morning for up to 8 weeks to induce remission. Because Uceris targets the colon directly, it offers a middle ground between topical rectal therapies and stronger systemic immunosuppressants for people whose colitis isn’t responding to milder treatments.
IgA Nephropathy
Budesonide delayed-release capsules (Tarpeyo) treat a kidney condition called primary IgA nephropathy, where an immune protein called immunoglobulin A builds up in the kidneys and triggers inflammation. The drug reduces proteinuria (excess protein spilling into the urine), which is a key marker of kidney damage and disease progression. This is a relatively newer use for budesonide, approved specifically for patients at risk of their kidney disease worsening over time.
Eosinophilic Esophagitis
Budesonide oral suspension is used to treat eosinophilic esophagitis (EoE), a condition where a type of white blood cell accumulates in the esophagus, causing swelling, difficulty swallowing, and food getting stuck. Patients swallow a viscous liquid form of budesonide that coats the esophagus on the way down. Clinical trials showed that 2 mg taken twice daily improved tissue inflammation, symptoms, and the visible damage seen on endoscopy in patients aged 11 to 55. A four-year follow-up study found that roughly half of patients maintained those improvements over the long term, and the drug’s FDA-approved oral suspension (Eohilia) is now available for this condition.
Side Effects by Formulation
Because budesonide comes in so many forms, side effects depend heavily on how you take it. Inhaled budesonide’s most well-known side effect is oral thrush, a fungal infection in the mouth and throat caused by the drug suppressing local immune defenses. Rinsing your mouth after each use significantly reduces this risk.
Oral capsules and tablets for gut conditions tend to cause headache, nausea, stomach pain, gas, and fatigue. Because more of the drug reaches the bloodstream with oral formulations, steroid-related effects like acne, weight gain, and decreased cortisol levels become more relevant, especially with longer courses.
The kidney formulation (Tarpeyo) carries a somewhat different side effect profile that reflects higher systemic steroid exposure: swelling in the legs and face, high blood pressure, muscle spasms, acne, and weight gain are all commonly reported. The oral suspension for eosinophilic esophagitis commonly causes respiratory infections, sore throat, and esophageal thrush.
Long-Term Steroid Concerns
Any corticosteroid taken over months or years can suppress the adrenal glands, which produce your body’s natural stress hormones. Budesonide is less likely to cause this than systemic steroids, but it’s not zero risk, particularly with oral formulations. Stopping budesonide abruptly after long-term use can trigger withdrawal symptoms like fatigue, joint pain, and dizziness as the adrenal glands take time to resume normal hormone production. Doctors typically taper the dose gradually to avoid this.
Drug Interactions to Know About
Budesonide is broken down in the liver by a specific enzyme system. Drugs that block this system slow budesonide’s clearance from the body, effectively increasing your dose without changing the number of pills you take. Common culprits include certain antifungal medications, some HIV medications, and grapefruit juice in large quantities. If you’re on any of these, your prescriber may adjust your budesonide dose or monitor you more closely for steroid-related side effects.